The global botulinum toxin market size is expected to reach around US$ 8,718.7 mn by the end of 2026. The analysts predict that this will happen as the market will grow a stable CAGR of 7.6% during the forecast period of 2019-2026. Increase in the prevalence of spasticity and cervical dystonia and the number of cases of migraine is expected to drive the botulinum toxin market during the forecast period. Surge in the rate of adoption of non-surgical botulinum toxin procedures, due to their noninvasive or minimally invasive nature, is boosting botulinum toxin market. Rise in the number of worldwide geriatric population and incidences of esthetic issues, such as crow’s foot and lateral canthal lines, is a key factor that is anticipated to propel the botulinum toxin market during the forecast period. However, lack of awareness regarding the advancements in non-surgical esthetic and therapeutic procedures is a major factors hampering revenue generation in the global botulinum toxin market.
The report analyzes and forecasts the botulinum toxin market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of botulinum toxin, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major botulinum toxin companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of botulinum toxin upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of botulinum toxin and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global botulinum toxin market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the botulinum toxin market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of botulinum toxin market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Mentioned in the Report
The report profiles major companies operating in the global botulinum toxin market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, recent developments, and SWOT (strength, weakness, opportunity, and threat) analysis. Major companies mentioned are Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc. (US), Lanzhou Institute of Biological Products Co. Ltd., and Revance Therapeutics, Inc.
Report Segmentation:
Global Botulinum toxin Market, by Product Type
Global Botulinum toxin Market, by Application
Global Botulinum toxin Market, by Region
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Botulinum Toxin Market
4. Market Overview
4.1. Introduction
4.1.1. by Product Type Definition
4.1.2. Market Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increasing demand for minimally invasive and non-invasive aesthetic and therapeutic procedures
4.3.1.2. Increase in prevalence of spasticity and cervical dystonia
4.3.1.3. Increasing number of products approval and new product launch in different region
4.3.1.4. Rising awareness regarding botulinum toxin procedures in the geriatric population worldwide
4.3.2. Restraints
4.3.2.1. Short time results and repetitive nature of aesthetic and therapeutic procedures
4.3.2.2. High cost of procedures and unavailability of reimbursement policies
4.3.3. Opportunities
4.3.3.1. Use of botulinum toxin products for the treatment of migraine and over sweating
4.3.3.2. Numerous products in phase III and above clinical trials for various disease conditions
4.4. Global Botulinum Toxin Market Analysis and Forecast, 2018–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Price Comparison Analysis (2017)
5.2. Pipeline Analysis
5.3. Launch and Patent Expiry - Snapshot
5.4. Key Trends
5.4.1. Increasing use of botulinum toxin aesthetic treatments by men
5.4.2. New and improved approaches regarding formulation types and delivery of botulinum toxin products
6. Global Botulinum Toxin Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Botulinum Toxin Market Value Forecast, by Product Type, 2018–2026
6.3.1. Botulinum Toxin Type A
6.3.2. Botulinum Toxin Type B
6.4. Market Attractiveness by Product Type
7. Global Botulinum Toxin Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Botulinum Toxin Market Value Forecast, by Application, 2018–2026
7.3.1. Aesthetic
7.3.2. Therapeutics
7.4. Global Botulinum Toxin Market Attractiveness, by Application
8. Global Botulinum Toxin Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Botulinum Toxin Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Botulinum Toxin Market Attractiveness, by Region
9. North America Botulinum Toxin Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Botulinum Toxin Market Value Forecast, by Product Type, 2018–2026
9.2.1. Botulinum Toxin Type A
9.2.2. Botulinum Toxin Type B
9.3. North America Botulinum Toxin Market Value Forecast, by Application, 2018–2026
9.3.1. Aesthetic
9.3.2. Therapeutics
9.4. North America Botulinum Toxin Market Value Forecast, by Country, 2018–2026
9.4.1. U.S.
9.4.2. Canada
9.5. North America Botulinum Toxin Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Application
9.5.3. By Country
10. Europe Botulinum Toxin Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Botulinum Toxin Market Value Forecast, by Product Type, 2018–2026
10.2.1. Botulinum Toxin Type A
10.2.2. Botulinum Toxin Type B
10.3. Europe Botulinum Toxin Market Value Forecast, by Application, 2018–2026
10.3.1. Aesthetic
10.3.2. Therapeutics
10.4. Europe Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2018–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Botulinum Toxin Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Application
10.5.3. By Country/Region
11. Asia Pacific Botulinum Toxin Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Botulinum Toxin Market Value Forecast, by Product Type, 2018–2026
11.2.1. Botulinum Toxin Type A
11.2.2. Botulinum Toxin Type B
11.3. Asia Pacific Botulinum Toxin Market Value Forecast, by Application, 2018–2026
11.3.1. Aesthetic
11.3.2. Therapeutics
11.4. Asia Pacific Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2018–2026
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Rest of Asia Pacific
11.5. Asia Pacific Botulinum Toxin Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Application
11.5.3. By Country/Region
12. Latin America Botulinum Toxin Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Botulinum Toxin Market Value Forecast, by Product Type, 2018–2026
12.2.1. Botulinum Toxin Type A
12.2.2. Botulinum Toxin Type B
12.3. Latin America Botulinum Toxin Market Value Forecast, by Application, 2018–2026
12.3.1. Aesthetic
12.3.2. Therapeutics
12.4. Latin America Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2018–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Botulinum Toxin Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Botulinum Toxin Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Botulinum Toxin Market Value Forecast, by Product Type, 2018–2026
13.2.1. Botulinum Toxin Type A
13.2.2. Botulinum Toxin Type B
13.3. Middle East & Africa Botulinum Toxin Market Value Forecast, by Application, 2018–2026
13.3.1. Aesthetic
13.3.2. Therapeutics
13.4. Middle East & Africa Botulinum Toxin Market Value Forecast, by Country/Region, 2018–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Botulinum Toxin Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by Tier and Size of companies)
14.2. Market Share Analysis by Company (2017)
14.3. Company Profiles
14.3.1. Allergan, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Ipsen Group
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Medytox, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Merz Pharma GmbH & Co. KGaA
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. US Worldmed, LLC
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.6. Nestlé Skin Health (Galderma)
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Metabiologics, Inc. (US)
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.8. Hugel Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Lanzhou Institute of Biological Products Co. Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Revance Therapeutics, Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers